N

Neurovance, Inc.

10 employees

Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Neuroscience
Health Care
Clinical Trials

Date founded

2011

Funding rounds raised

Total raised

$6.5M

from 5 investors over 5 rounds

N

Neurovance, Inc. raised $6.5M on June 29, 2015

Investors: Venture Investors

N

Neurovance, Inc. raised $6.3M on April 3, 2014

Investors: GBS Venture Partners, State of Wisconsin Investment Board, Tekla Capital Management and Venture Investors

FAQ